With box warnings

Without box warnings

Branded

Generic

2 results

pemazyre
(pemigatinib)
Incyte Corporation
Usage: PEMAZYRE is indicated for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement, and for adults with relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement.
tibsovo
(ivosidenib)
Servier Pharmaceutical LLC
Usage: TIBSOVO is indicated for treating newly diagnosed acute myeloid leukemia (AML) with an IDH1 mutation, relapsed or refractory AML, relapsed or refractory myelodysplastic syndromes (MDS), and previously treated locally advanced or metastatic cholangiocarcinoma with an IDH1 mutation in adults.

Medications for Cholangiocarcinoma

pemazyre